Gan, X.; Li, S.; Wang, Y.; Du, H.; Hu, Y.; Xing, X.; Cheng, X.; Yan, Y.; Li, Z.
Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer. Int. J. Mol. Sci. 2023, 24, 5482.
https://doi.org/10.3390/ijms24065482
AMA Style
Gan X, Li S, Wang Y, Du H, Hu Y, Xing X, Cheng X, Yan Y, Li Z.
Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer. International Journal of Molecular Sciences. 2023; 24(6):5482.
https://doi.org/10.3390/ijms24065482
Chicago/Turabian Style
Gan, Xuejun, Shen Li, Yiding Wang, Hong Du, Ying Hu, Xiaofang Xing, Xiaojing Cheng, Yan Yan, and Ziyu Li.
2023. "Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer" International Journal of Molecular Sciences 24, no. 6: 5482.
https://doi.org/10.3390/ijms24065482
APA Style
Gan, X., Li, S., Wang, Y., Du, H., Hu, Y., Xing, X., Cheng, X., Yan, Y., & Li, Z.
(2023). Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer. International Journal of Molecular Sciences, 24(6), 5482.
https://doi.org/10.3390/ijms24065482